Kovitz Investment Group Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,448
Closed -$367K 682
2025
Q3
$367K Buy
5,448
+1,818
+50% +$144K ﹤0.01% 1128
2025
Q2
$317K Sell
3,630
-3,174
-47% -$249K ﹤0.01% 1123
2025
Q1
$465K Sell
6,804
-17,953
-73% -$1.47M ﹤0.01% 925
2024
Q4
$1.93M Buy
+24,757
New +$1.83M 0.01% 578

Other funds holding DXCM

Kovitz Investment Group Partners's DXCM Position: Q4 2025 in Review

Kovitz Investment Group Partners sold out of DexCom (DXCM) in Q4 2025, closing a stake of 5,448 shares — an estimated $367K sold.

Kovitz Investment Group Partners first reported a position in DXCM in Q4 2024 and held it in 4 quarters. The position peaked at $1.93M in Q4 2024. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Kovitz Investment Group Partners reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 5,448 DexCom shares in Q4 2025, an estimated $367K.
  • Kovitz Investment Group Partners first reported a position in DexCom in Q4 2024 and held it in 4 quarters.
  • Kovitz Investment Group Partners's DexCom position peaked at $1.93M in Q4 2024.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Kovitz Investment Group Partners's 13F filing for Q4 2025, filed 20 Feb 2026.